Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ORrep8, I agree with you. Ethicon already makes tools for Intuitive, that's a known fact. So my thought was, if they decide to make tooling for Titan, should not be a big deal since they make it for Intuitive UNLESS they are also deciding to invest in SPORT. JnJ stated on March 27 they were partnering with Google to bring a novel surgical robotic platform to market. Obviously Intuitive now knows that they will have to compete with Warren Robotics at some point in the future, the big question for them would be WHEN? The info that was given is showing that Warren robotics is 2-3 years from market UNLESS they have/are investing in a surgical robotics platform that could be ready within 1 to 1 1/2 years (HALF THE TIME). If it was announced that JnJ was the supplier, it would almost validate the theory that they plan to partner with Titan which would put Intuitive in a position to have to react quicker than 3 years. Also interesting that they pulled their Single Port DaVinci.
If any other posters have thoughts on the worldwide supplier and why they haven't been disclosed, I would like to hear them. For my investment in Titan, that is something that i have an opinion on but I would like to hear what others think b/c I have gone thru several theories but can't make them stick. My theory is that it is JnJ, the timeline works out and JnJ's hiring spree over the last 3+ months of Surgical Robotics engineers for just tooling/End Effectors would fit into my theory. What I can't figure out though, even if it is JnJ, why not just announce it? If it is Microline, why not just announce it? For example with Microline, why would they want to keep it secret, the would benefit just as much from announcing as titan would. It would signal that Microline is a player in this exploding growth market.
First, I know they didn't decide to BS the market b/c this isn't he California Penal League. Second, and I have posted this before, I believe Craig Leon got bought out at a certain phase. As for the Business development guy, they are a dime a dozen.
Fair point but why not announce it since the supplier will be developing tools that are only applicable to SPORT and no other system? Unless they are already supplying tools for the only robotic system on the market. An annoucement like that would absolutely have gotten the PPS up enough to possibly uplift
http://www.titanmedicalinc.com/titan-medical-inc-signs-agreement-with-worldwide-supplier-of-single-patient-use-robotic-tools/
No, that reason doesn't convince me. Saying that they bs'd the press release doesn't hold water. Why would the supplier not want to be revealed? Think bigger.
Note on the WorldWide Supplier: I've been thinking about this a ton and have been trying to figure out why it has been secret or kept under wraps. Obviously, once they announce whoever it is (Ethicon, Microline, Medtronic, etc), the PPS will go up significantly (several dollars/share) so why not have disclosed it once the agreement was signed? My theory is that the worldwide supplier in their contract with Titan specifically stated that they did not want to be revealed, which Titan agreed too which means that they have significant clout and skin in the game when it comes to Titan SPORT.
Any other theories as to why the supplier has requested they remain anonymous for now?
On the record, one SPORT will be sold before one Surgibot - you can etch that in stone. TRXC won't get approval for Surgibot in Q1
Interesting that your alias is LONGTERMGEMS b/c you don't even know what that means.
Im still on record saying that one SPORT will be sold before one surgibot. Also noticed that TRXC is still looking to hire engineers (has been for over 6 months) to complete surgibot - they don't the manpower or the expertise on the engineering and design side.
I was certain that LTG was giving unbiased and accurate info on TITXF - man am I screwed, I mean he said their was a death cross so why should i doubt the death cross.
Who would have thought about calling the company.
Make sure that when you call you use the ihub names - that might impress them or scare them, either way your phone call will be remembered
More job postings at ethicon for engineers and designers of end effectors for a novel surgical robotic platform. AND AGAIN not one mention of engineers and designers for the surgical robotic platform itself. Obviously Ethicon is ramping up personnel and production of surgical robotic end effectors/tools.
10, 15, 18...the point i'm making is that it could be a potential agreemenet to purchase once the agreement is in place - if that is the case and it was a PO for the Titan SPORT - that alone would send the stock way up - certainly would get the warrants excercised (june 2016 and beyond) - of course we won't know until the exclusive agreement with Longtai is finalized - it does make some sense considering Longtai is building 2 State of the ART healthcenters in China - which would be featuring robotic surgery
Could the $15m from longtai be an initial PO for 10 robots?
Back to the post regarding CRO - clinical trails - there are pieces to this puzzle all Round us if u do your due diligence - check my old post #25265
What? Most companies use CRO's to do clinical trials. Are you kidding me with that statement. That is UNBELIEVABLE that you can't believe a company outsources clinical trials - I am in complete shock that I just read this post.
This statement and Point's statement about dumping shares have to be the two most unbelievable things i've read on this board. It falls under the category of "Emotionally unintelligent"
Obviously he was fed up when he was dumping shares after the AGM but implied otherwise to the board.
That is only if you believe points article which would be a shame if u still put stock in that article (No pun intended)
Earnings? They have no earnings much like TRXC has no earnings, in fact TR XC has actually had a revenue go down to zero
How can it be up 90% if it was at $14 PPS just a year ago? This post shouldn't be deleted because it's in reference to a post a couple of hours ago about TRX see being up 90%
Agreed, my take on it is that the demand for the shares and warrants is greater than the supply so they have agreed to allow Octagon to issue up to 15% of share offering in over-allotment. An interesting point on this release is that it is for Octagon only, not for the US private placement. IMO and from what i've researched, the private placement deal is potentially already done.
My understanding that if a private placement is announced as a form of offering then it has already been agreed upon with the buyer. Hence, we won't get a crack at those shares, they will have already been bought either by Bank, institution, VC, etc.
I heard that they will have to pay/beg a distributor for them to even look at surgibot. No distributor wanted to touch ALF, hence they sell for $100m, no distributor wanted it
Dumbest idea I've heard.
I'm going to put down millions and millions of dollars to buy ximedica but stop them from doing what they do best and ruin their reputation, brand and future clients who want to use ximedica services. REALLY?
Also, that $4M from Longtai at the completion of the deal (May 16, 2016) is in play. We also don't know about the add'l $15M from Longtai that could also come once the deal is signed (May 17, 2016). No one is taking into account that the Longtai Deal could be finalized sooner than 183 days. Maybe its finalizing by end of year - that then puts an add'l $4M with the other $15M ($19M total) on the books by Jan 1 2016 - more than enough to get to CE mark - announcement of Q4 milestone achievement next week will get warrants excercised - that makes another $6M.
I realize that this is guessing that this might happen but it is no different than guessing that another scenario could happen.
maybe your math might be off, we have to see the baseline cash position from the financials on Nov 13 - if they have a cash position of $8-10M without the new funds and have the 11 prototypes complete, they can achieve CE Mark and get it selling in Asia Pacific (especially if Longtai places an upfront PO for X amounts of systems)
a little more clarification on new SEDAR posting regarding Titan agreement with Longtai - I've read this new update 4 times and the PR on Friday several times and I keep coming up with the same conclusion - Longtai will be selling SPORT in Asia Pacific by summer of 2016. The only reason they wouldn't is if they don't get the deal done over the next 183 days (which is May 16, 2016)
Thanks Ted
We will have over 1m Shares exchanged today and it settles at $1.08-$1.10. Plus some institutional investors will take a position in the company (bertner is doing what she is paid to do).
Another great point. It's amazing that some people can't hear themselves.
Great point
They could also have completed the 11 prototypes and want to accelerate their timelines (Clinical Trials, CE Mark, FDA, etc). It truly depends on what they need the money for - if it is to accelerate the timelines and get to commercialization quicker in Asia Pacific, I would be ok with that.
I think that it is interesting that they don't list the US Placement Agent but do mention the Canadian agent.
the optimistic outlook would be they need the money to ramp up manufacturing of SPORT to meet Longtai's expected initial purchase once the agreement is in place.
The other point regarding the language at the end:
"The net proceeds of the Offering will be used for ongoing development and commercialization of robotic surgical technologies"
could indicate a multi-port system as well.
Thanks IITF, this is what I was referring to from the PR from Titan regarding Longtai:
"Under the terms of the Letter Agreement, Longtai will subscribe for and purchase US$4,000,000 worth of Common Shares of Titan under a private placement"
IMO, they had to go to the shelf, how else are they going to offer the private placing financing to Longtai?
Am i missing something or was there another way they were going to do the private placement with Longtai?
I was ok with him until he shared with the board that he was unloading shares after the AGM even though he had implied positive news and an article coming after the AGM
Here is an example of how Ethicon can work with a company thru distributorship, since we know we won't get an answer from the previous post
http://www.ethicon.com/healthcare-professionals/support/distribution-choices
I know that Longtai is interested enough to plunk down $24M to sell SPORT from Titan (TITXF) - i think they would be very incentivized to get that money back quickly.
How's the sales team coming at the other company?
why?